Global Gluten Intolerance Treatment Market Size study, by Drug Type (Antihistamines, Epinephrine), by Indication (Celiac Disease, Dermatitis Herpetiformis, Depression, Gluten Ataxia), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pha

Global Gluten Intolerance Treatment Market Size study, by Drug Type (Antihistamines, Epinephrine), by Indication (Celiac Disease, Dermatitis Herpetiformis, Depression, Gluten Ataxia), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) and Regional Forecasts 2022-2032

Global Gluten Intolerance Treatment Market was valued at approximately USD 596.48 million in 2023 and is anticipated to grow at a remarkable CAGR of 13.98% over the forecast period from 2024 to 2032. Gluten intolerance, also known as non-celiac gluten sensitivity (NCGS), is a condition characterized by adverse reactions to gluten, a protein found in wheat, barley, and rye. Gluten intolerance can lead to symptoms such as bloating, abdominal pain, diarrhea, fatigue, and headaches. Treatment for gluten intolerance primarily involves adopting a gluten-free diet, which means avoiding all foods that contain gluten. This can be challenging as gluten is a common ingredient in many processed foods. People with gluten intolerance must read labels carefully and be aware of potential sources of gluten in their diet. Additionally, some individuals may benefit from working with a dietitian to ensure they maintain a balanced and nutritious diet while avoiding gluten.

The Global Gluten Intolerance Treatment Market is experiencing robust growth driven by growing prevalence of celiac diseases and heightened awareness regarding early diagnosis across the world. As more people worldwide are being diagnosed with gluten intolerance and related disorders, the demand for effective treatment options has surged. This has led to significant advancements in medical research and the development of innovative therapies. Additionally, the rising awareness among the general population about the symptoms and long-term health impacts of gluten intolerance has prompted more individuals to seek medical advice and intervention. Consequently, the market is expanding rapidly, with healthcare providers, pharmaceutical companies, and medical device manufacturers all playing a crucial role in meeting the growing needs of this patient population. Furthermore, the pharmaceutical industry is witnessing increased demand for gluten intolerance treatments, which is propelling market expansion. Moreover, government and non-government expenditure on healthcare and advancements in pharmaceutical research and development is anticipated to create lucrative opportunities for the market. However, high cost of advanced treatments is going to impede the overall demand for the market during the forecast period 2024-2032.

The key regions considered for the Global Gluten Intolerance Treatment Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. In 2023, North America held a dominant position in the gluten sensitivity management landscape and this trend is expected to continue throughout the forecast period. This dominance is due to a higher rate of gluten intolerance diagnoses and the growing demand for advanced-level treatments in the region. On the other hand, Asia Pacific is projected to experience significant market growth due to increased healthcare expenditure by government and non-government agencies aimed at combating celiac disease.

Some of the major market players included in this report are:

Precigen ActoBio

Calypso Biotech SA

Alvine Pharmaceuticals, Inc.

ImmusanT

Artielle ImmunoTherapeutics

FunZyme Biotechnologies

Innovative BioPharma

AMYRA Biotech AG

Vactech Composites Pvt. Ltd.

Alba Therapeutics Corporation

PvP Biologics, Inc.

The detailed segments and sub-segment of the market are explained below:

By Drug Type:
• Antihistamines
• Epinephrine

By Indication:
• Celiac Disease
• Dermatitis Herpetiformis
• Depression
• Gluten Ataxia

By Distribution Channel:
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

By Region:

North America
• U.S.
• Canada

Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE

Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC

Latin America
• Brazil
• Mexico
• RoLA

Middle East & Africa
• Saudi Arabia
• South Africa
• RoMEA

Years considered for the study are as follows:
• Historical year – 2022
• Base year – 2023
• Forecast period – 2024 to 2032

Key Takeaways:
• Market Estimates & Forecast for 10 years from 2022 to 2032.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.